site crawlran 15m ago·16 May, 14:40·runs daily 06:00
Click any tile above to filter the table. Click any row to expand and see the full meta, schemas, alt text, H2 counts, links, depth, and per-page tools (View live · Test schema · PageSpeed). Click Edit next to Title or Meta to change the value live.
Ipamorelin vs Sermorelin: GHRP vs GHRH (UK research use only)
Meta description (163 chars)
UK editorial comparison of Ipamorelin and Sermorelin. Different receptor classes (GHRP vs GHRH), different mechanisms, often paired in research. Research use only.
my-peptides vs Direct Sarms (UK): research peptide retailer comparison
Meta description (170 chars)
UK comparison of my-peptides and Direct Sarms. Both ship research peptides to the UK. Peptide-only vs peptide-plus-SARMs catalogue, payment, delivery, regulatory framing.
Phlo vs Pharmacy2U (UK): which low-touch GLP-1 pharmacy fits
Meta description (155 chars)
UK comparison of Phlo and Pharmacy2U GLP-1 online pharmacies. Pricing, app vs web, NHS compatibility, range, audience fit. Both low-touch, different shape.
Numan vs Voy (UK): which high-touch GLP-1 clinic fits
Meta description (159 chars)
UK comparison of Numan and Voy GLP-1 clinics. Pricing, programme shape, aftercare framing, switch policies, audience fit. Both high-touch. Different strengths.
BPC-157 vs TB-500 (UK): research peptide encyclopedia comparison
Meta description (169 chars)
UK encyclopedia comparison of BPC-157 and TB-500. Origin, animal literature, regulatory status, retailer availability. Research use only, no human-use claims, no dosing.
Hooke vs Echelon Health: UK longevity clinic comparison
Meta description (177 chars)
UK editorial comparison of Hooke and Echelon Health. Two of the leading UK longevity clinics. Imaging-led vs measurement-and-intervention models. Pricing, packages, focus areas.
Numan vs Phlo (UK): high-touch clinic vs low-touch pharmacy
Meta description (155 chars)
UK comparison of Numan (high-touch GLP-1 clinic) and Phlo (low-touch GLP-1 pharmacy). Different products at different price points. Which suits which user.
my-peptides vs Pure Peptides UK: research peptide retailer comparison
Meta description (164 chars)
UK comparison of my-peptides and Pure Peptides UK research peptide retailers. Purity claims, CoA process, range, delivery, payment. Editorial. Affiliate disclosure.
Numan vs Juniper (UK): which GLP-1 clinic suits women better
Meta description (179 chars)
UK comparison of Numan and Juniper for women. Menopause-aware care, HRT coordination, pricing, programme shape. Juniper is the perimenopausal default; Numan is the broader option.
Wegovy vs Saxenda (UK): newer weekly vs older daily GLP-1
Meta description (174 chars)
UK editorial comparison of Wegovy (semaglutide, weekly) and Saxenda (liraglutide, daily). Older vs newer Novo Nordisk GLP-1s. Efficacy, dosing, cost, and prescribing context.
GHK-Cu vs Matrixyl 3000 (UK): which cosmetic peptide for what
Meta description (219 chars)
UK comparison of GHK-Cu copper peptides and Matrixyl 3000 in cosmetic skincare. Mechanism, evidence base, formulation requirements, what to layer with, and which serums actually deliver them at meaningful concentration.
Type I vs Type II collagen: skin and tendon vs joint
Meta description (178 chars)
UK editorial comparison of Type I and Type II collagen. Different molecules, different doses, different goals. Type I in grams for skin; Type II (UC-II) in milligrams for joints.
Tesamorelin vs Sermorelin: longer GHRH analogue compared
Meta description (175 chars)
UK editorial comparison of Tesamorelin and Sermorelin. Both GHRH analogues. Different lengths, different stability, different regulatory profiles. Research use only in the UK.
Mounjaro vs Wegovy (UK): how they differ and which prescribers pick
Meta description (232 chars)
UK editorial comparison of Mounjaro (tirzepatide) and Wegovy (semaglutide). Mechanism, dosing schedules, side effect profile, weight loss data, UK pricing, and which prescribers tend to pick when. Editorial. Your prescriber decides.
CJC-1295 vs Sermorelin: GHRH analogues compared (UK research use only)
Meta description (174 chars)
UK editorial comparison of CJC-1295 and Sermorelin. Both GHRH analogues. Different amino acid length, different half-lives, different research positioning. Research use only.
Bare Biology vs Vital Proteins: UK marine collagen compared
Meta description (157 chars)
UK editorial comparison of Bare Biology and Vital Proteins marine collagen. UK independent vs global brand. Dose, kDa, sourcing transparency, price per gram.
Hydrolysed vs native collagen: absorption and dose explained
Meta description (206 chars)
UK editorial comparison of hydrolysed and native collagen forms. Why hydrolysed dominates the supplement market, where native (undenatured Type II) makes sense, and what "peptides" on a label means.
Juniper vs Voy (UK): which women-focused GLP-1 clinic
Meta description (162 chars)
UK comparison of Juniper and Voy for women. Both have strong women-skewed programmes. Menopause-aware care, aftercare framing, pricing, HRT coordination compared.
Marine vs bovine collagen: which to choose in 2026
Meta description (166 chars)
UK editorial comparison of marine and bovine collagen. Type composition, kDa molecular weight, source transparency, absorption, price per gram. Which fits which goal.
UK longevity clinics: TRT, hormones, comprehensive bloods compared
Meta description (165 chars)
UK longevity clinic comparison. Hooke, HUM2N, OneWelbeck, Leger, Balance My Hormones, Optimale. TRT pathway, comprehensive bloods, biological age testing. Editorial.
Cosmetic peptides UK: skincare with GHK-Cu, Matrixyl, palmitoyl tripeptides
Meta description (214 chars)
UK guide to cosmetic peptides in skincare. GHK-Cu copper peptides, Matrixyl 3000, palmitoyl tripeptide-1, argireline. What concentrations matter. UK serums compared. Affiliate via Boots, Cult Beauty, LookFantastic.
Matrixyl 3000 UK: what it is, where to find it, what to ignore
Meta description (207 chars)
Matrixyl 3000 is a branded blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. UK skincare with real Matrixyl 3000 listed at meaningful concentration. What "contains Matrixyl" really means.
GHK-Cu copper peptide UK: what it is, what concentration matters
Meta description (207 chars)
UK guide to GHK-Cu copper peptide skincare. What it is, how it works, what concentration matters in UK serums. Boots, Cult Beauty, LookFantastic stockists. Affiliate disclosure: we earn from outbound clicks.
Get in touch with UK Metabolic. Editorial, partnership, clinic listing, or feedback. We reply within 1 working day. We are not a pharmacy and cannot answer dose-specific medical questions.
UK GLP-1 weight management medications: Mounjaro, Wegovy, Saxenda
Meta description (169 chars)
Editorial reference on the three GLP-1 medications licensed in the UK for weight management. Mechanism, dosing, evidence base, NHS and private access, cost, comparisons.
Saxenda (liraglutide) UK reference (2026): mechanism, dosing, access, cost
Meta description (202 chars)
Comprehensive UK editorial reference for Saxenda (liraglutide). Daily-injection GLP-1, largely superseded by Wegovy and Mounjaro. SCALE trial evidence, NHS TA664, paediatric experience, UK availability.
Editorial director of UK Metabolic. Director of Best Business Loans Ltd, the UK company that operates the site. Editorial principles, source hierarchy, conflict of interest, and corrections policy.
Will I regain the weight after stopping Mounjaro? (UK 2026)
Meta description (300 chars)
82 percent of patients regain at least 25 percent of lost weight within 12 months of stopping (Oxford analysis, January 2026). Without active maintenance protocols, partial regain is the rule rather than the exception. Resistance training and protein at 1.2 to 1.6 grams per kilogram of goal body wei
I missed a dose of Mounjaro, what should I do? (UK 2026)
Meta description (300 chars)
Mounjaro 4-day rule: if you remember within 4 days of the missed dose, take it as soon as possible and continue the original weekly schedule. If more than 4 days have passed, skip the missed dose entirely and take the next scheduled dose on the usual day. Never double up to compensate. The Wegovy eq
Yes. Mounjaro can reduce the effectiveness of combined and progestogen-only oral contraceptive pills because tirzepatide slows gastric emptying, which delays and reduces absorption of the pill. The Lilly Patient Information Leaflet recommends adding a barrier method (condom or diaphragm) or switchin
Can I take GLP-1 medications during pregnancy? (UK 2026)
Meta description (300 chars)
No. Mounjaro, Wegovy, and Saxenda are all contraindicated in pregnancy in the UK. The MHRA-approved Patient Information Leaflets advise stopping GLP-1 medication at least 2 months before trying to conceive. If you become pregnant unexpectedly while on a GLP-1, contact your prescriber the same day. B
NHS Mounjaro is available under NICE TA1026 in three phased cohorts. Cohort 1 (BMI 40+, 4+ comorbidities) has been live since June 2025. Cohort 2 launches 23 June 2026 (BMI 35+, 3+ comorbidities). Cohort 3 is expected April 2027 (BMI 30+, 2+ comorbidities). Ethnicity-adjusted thresholds are 2.5 kg/m
Yes. The typical UK protocol leaves a 7-day washout between the last Wegovy dose and the first Mounjaro dose. The first Mounjaro dose is 2.5 mg regardless of prior Wegovy maintenance dose; the patient then titrates monthly on the standard Mounjaro ladder (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg). Some pre
UK FAQ on cosmetic peptide skincare. What concentration matters, how to layer, when results show, GHK-Cu vs Matrixyl, side effects, pregnancy safety. FAQPage schema for AI search.
Argireline is the brand name for acetyl hexapeptide-8, a 6-amino-acid cosmetic peptide marketed as a topical line-reduction ingredient. The mechanism is to inhibit muscle contraction at the skin surface, analogous to (but vastly weaker than) botulinum toxin. Manufacturer-supported in-vitro and small
Can you stack peptides and vitamin C in the same routine?
Title tag (67 chars)
Can you stack peptides and vitamin C in the same routine? (UK 2026)
Meta description (300 chars)
Generally yes, but separate them by time and watch the pH. Copper peptides (GHK-Cu) are destabilised by low-pH L-ascorbic acid vitamin C in the same step; use vitamin C in the morning and copper peptides at night, or use a pH-neutral vitamin C form (sodium ascorbyl phosphate, magnesium ascorbyl phos
What does INCI position mean for cosmetic peptides?
Title tag (61 chars)
What does INCI position mean for cosmetic peptides? (UK 2026)
Meta description (300 chars)
INCI (International Nomenclature of Cosmetic Ingredients) is the standardised ingredient list on every cosmetic product. Ingredients are listed in descending order of concentration above 1 percent; ingredients below 1 percent can be listed in any order at the end. A peptide in the top 8 INCI ingredi
GHK-Cu is glycyl-histidyl-lysine bound to copper, a small tripeptide-copper complex isolated from human plasma by Loren Pickart in 1973. It is the most-studied cosmetic peptide. The complex appears to signal collagen synthesis, glycosaminoglycan synthesis, and angiogenesis in skin cells. Cosmetic se
Matrixyl 3000 is a branded cosmetic peptide complex from French ingredient maker Sederma, combining palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. Both are signal peptides that appear to stimulate collagen and glycosaminoglycan synthesis. Matrixyl 3000 is among the most commercially recognised
Why does copper peptide packaging matter? (UK 2026)
Meta description (300 chars)
Copper peptide molecules oxidise on prolonged air exposure, particularly in clear jars where light also reaches them. The blue tint of a fresh GHK-Cu serum is the copper bound to the peptide; loss of colour indicates degradation. Airless pump bottles and opaque packaging slow oxidation. Jars with sc
No plant supplement contains collagen. "Vegan collagen" products contain amino acid precursors (lysine, proline, glycine) plus vitamin C and assume the body builds its own collagen from those inputs. Honest brands label this clearly as "collagen builder" or "collagen support"
What is the best time of day to take collagen? (UK 2026)
Meta description (300 chars)
For tendon and connective tissue goals: 60 minutes before exercise, as in the Shaw 2017 protocol (15 g hydrolysed collagen plus 50 mg vitamin C). For skin goals: any consistent daily time. For UC-II Type II joint goals: any time, but consistency on the same time each day supports the oral tolerance
Why is vitamin C taken alongside collagen? (UK 2026)
Meta description (300 chars)
Vitamin C is the essential cofactor for the enzymes that convert ingested collagen and amino acids into structural collagen in your body. Without adequate vitamin C, the hydroxylation steps that stabilise the collagen triple helix do not proceed efficiently. The strongest collagen RCT for tendon out
What is the difference between Type I and Type II collagen?
Title tag (69 chars)
What is the difference between Type I and Type II collagen? (UK 2026)
Meta description (300 chars)
Type I and Type II are different molecules taken at different doses for different goals. Type I is the dominant collagen in skin, hair, nails, tendons, and bone; taken hydrolysed at 5 to 15 grams per day. Type II is the dominant collagen in cartilage; taken undenatured (UC-II) at 40 milligrams per d
How much collagen should I take per day? (UK 2026)
Meta description (300 chars)
For hydrolysed Type I collagen aimed at skin and tendon: 10 to 15 grams per day is the dose used in most published trials, including the strongest evidence (Shaw 2017 at 15 grams pre-exercise for tendon outcomes). For undenatured Type II UC-II aimed at joints: 40 milligrams per day. The dose unit (g
Marine or bovine collagen, which should I choose? (UK 2026)
Meta description (300 chars)
Marine collagen is almost entirely Type I, sourced from fish skin and scales, typically the smallest molecular weight (1 to 3 kDa). Bovine collagen is Type I and Type III combined, sourced from cow hide, typically 3 to 6 kDa. Marine is the better match for skin and tendon goals because Type I domina
Research peptides FAQ (UK): legality, regulation, what HPLC means
Meta description (166 chars)
UK FAQ on research peptides. Legal status, MHRA enforcement, what HPLC purity proves, why no human RCTs, what "research use only" means. Encyclopedia framing.
Are research peptides on the WADA prohibited list?
Title tag (60 chars)
Are research peptides on the WADA prohibited list? (UK 2026)
Meta description (300 chars)
Yes. Most research peptides commonly sold in the UK appear on the World Anti-Doping Agency (WADA) prohibited list under section S2 (peptide hormones, growth factors and related substances). BPC-157, TB-500, MOTS-c, Ipamorelin, GHRP-2/6, CJC-1295, Tesamorelin, Sermorelin, and IGF-1 are all prohibited
What does 99% HPLC purity actually mean? (UK 2026)
Meta description (300 chars)
A 99 percent HPLC purity claim means that when a sample of the peptide is run through high-performance liquid chromatography, at least 99 percent of the detectable peptide content is the named molecule. It is the standard purity benchmark for UK research peptide retailers. HPLC does not prove biolog
How are research peptides stored and handled? (UK 2026)
Meta description (300 chars)
Research peptides ship lyophilised (freeze-dried) as a white powder in sealed glass vials. Lyophilised peptides are reasonably stable at room temperature for short transit, and substantially more stable when refrigerated (2 to 8°C, 6 to 12 months) or frozen (minus 18°C or colder, 12 to 24 months). O
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein originally identified in human gastric juice. The Sikiric research group at the University of Zagreb has published most of the preclinical literature on it since 2003, primarily on tendon healing, gut
What does "research use only" actually mean? (UK 2026)
Meta description (300 chars)
"Research use only, not for human or animal consumption" is the regulatory framing under which research peptides without UK MHRA marketing authorisation are sold in the UK. The wording positions the product outside the medicines tier of the Human Medicines Regulations 2012. It is not a posit
Most research peptides commonly sold in the UK (BPC-157, TB-500, MOTS-c, Ipamorelin, Sermorelin, Tesamorelin, CJC-1295) are not controlled under the Misuse of Drugs Act 1971 and not scheduled under the Psychoactive Substances Act 2016. They have no UK MHRA marketing authorisation as medicines but ar
Encyclopedia: peptides, GLP-1, collagen, UK regulators explained
Meta description (166 chars)
Plain-English UK encyclopedia entries on peptides, collagen, GLP-1 medications, NHS rollout, body composition measurement, and the regulators behind them. 39 entries.
UK medicines are classified into three tiers: Prescription Only Medicine (POM), Pharmacy (P), and General Sales List (GSL). The classification determines who can supply, where, and with what advertising.
NICE TA1026 explained: tirzepatide for weight management
Meta description (191 chars)
NICE Technology Appraisal 1026 (2024) is the UK guidance defining who qualifies for NHS Mounjaro under the phased rollout. BMI thresholds, comorbidity requirements, and discontinuation rules.
NHS England is rolling Mounjaro out for weight management in three cohorts by BMI and comorbidity count. Cohort 1 live since June 2025. Cohort 2 launches June 2026.
A wearable sensor that reports interstitial glucose every 1 to 5 minutes for 10 to 14 days. Originally for diabetes; now used in longevity and metabolic health monitoring. UK availability and what GLP-1 users see on a CGM.
Specialist Weight Management Service (SWMS) explained
Meta description (188 chars)
NHS tier-3 service providing multi-disciplinary support for severe obesity. The commissioning route through which NHS Mounjaro is delivered in most ICBs. Referral, structure, what they do.
Sleep apnoea as a GLP-1 eligibility comorbidity explained
Meta description (196 chars)
Obstructive sleep apnoea (OSA) counts toward NICE TA1026 comorbidity eligibility for NHS Mounjaro. The diagnostic threshold, the link to obesity, and why GLP-1 outcomes for OSA are now in the SPC.
The Advertising Standards Authority enforces the CAP code on UK advertising. POM weight-loss medications cannot be advertised to the public. The September 2025 enforcement notice in plain English.
Muscle preservation on GLP-1: protein, training, sleep
Meta description (167 chars)
Three levers preserve muscle during rapid GLP-1 weight loss: adequate protein, resistance training, sleep. The framework most clinics align to. Plus the evidence base.
kDa is the unit of molecular weight on collagen labels. 2 to 3 kDa marine collagen absorbs better than 5 to 6 kDa bovine, because smaller peptides cross the gut wall more efficiently.
Peptide storage and handling explained (lyophilised, reconstituted)
Meta description (207 chars)
Most research peptides arrive lyophilised (freeze-dried) and stable at room temperature for short periods. Once reconstituted with bacteriostatic water, refrigeration is required and stability drops sharply.
Oral tolerance and undenatured Type II collagen explained
Meta description (186 chars)
The immune mechanism behind UC-II Type II collagen for joint comfort. Why 40 mg of undenatured Type II is taken instead of grams of hydrolysed. Different mechanism, different dose units.
HbA1c explained: the 3-month average glucose marker
Meta description (244 chars)
HbA1c (glycated haemoglobin) reflects average blood glucose over the previous 8 to 12 weeks. The standard NHS marker for diabetes diagnosis, control, and pre-diabetes screening. UK reference ranges and what GLP-1 medications typically do to it.
Protein intake on GLP-1: why it matters for muscle preservation
Meta description (182 chars)
GLP-1 medications suppress appetite, including for protein-rich foods. Insufficient protein during rapid weight loss accelerates muscle loss. The mechanism and the practical context.
Visceral fat sits inside the abdominal cavity around the organs. Metabolically active and the key driver of cardiometabolic risk. How it differs from subcutaneous fat, how it is measured, and what GLP-1 medications do to it.
Every licensed UK GLP-1 starts at a low introductory dose and titrates monthly to maintenance. Why this matters, what the SPC says, and what happens if the patient does not tolerate the next step.
Licensed GLP-1 medications ship under refrigerated cold chain (2 to 8°C). Why this matters, what validated cold-chain logistics look like, and the out-of-fridge window once delivered.
A CoA is a third-party lab document confirming purity, identity, and sometimes additional properties of a chemical sample. What it proves, what it does not, and the difference between provided-with-order and on-request.
NICE recommends a 2.5 kg/m² downward BMI adjustment for South Asian, Chinese, Black African and African-Caribbean populations. The rationale is higher metabolic risk at lower BMI in those populations.
Dual-energy X-ray absorptiometry measures body composition: fat mass, lean mass, bone mineral content, regional distribution. The gold standard against which BMI, bioimpedance and tape-measure methods are validated.
Hypertension as a GLP-1 eligibility comorbidity explained
Meta description (195 chars)
Hypertension is the most common weight-related comorbidity counted toward NICE TA1026 NHS Mounjaro eligibility. UK diagnostic thresholds, the obesity link, and outcomes data on GLP-1 medications.
VO2 max explained: the cardiorespiratory fitness measure
Meta description (247 chars)
VO2 max is the maximum rate of oxygen consumption during exhaustive exercise. The single best predictor of all-cause mortality after adjusting for other factors. How it is measured, what good values look like, and how GLP-1 weight loss affects it.
Two gut hormones underpin the modern weight-loss medications. Wegovy targets GLP-1 alone; Mounjaro targets both GLP-1 and GIP. The dual-agonist mechanism is why Mounjaro outperformed Wegovy in head-to-head data.
Bariatric surgery vs GLP-1 medications: the UK pathways compared
Meta description (193 chars)
Bariatric surgery (gastric sleeve, gastric bypass) and GLP-1 medications are complementary NHS pathways, not competing options. Tier 3 GLP-1 typically trialled before Tier 4 surgery escalation.
WADA prohibited list and peptides: what tested athletes need to know
Meta description (203 chars)
The World Anti-Doping Agency prohibits several research peptides under section S2 (peptide hormones, growth factors). BPC-157, TB-500, MOTS-c, Ipamorelin and SARMs all appear. Tested athletes must avoid.
RMR is the energy your body uses at rest. Falls during weight loss, including on GLP-1. How RMR is measured, why it matters for maintenance after goal weight, and what determines individual variation.
"Research use only" framing explained (UK research peptides)
Meta description (179 chars)
The regulatory wording under which research peptides are sold in the UK. What it does and does not authorise, why the framing matters, and where it sits relative to medicines law.
Compounded vs licensed GLP-1: the UK position explained
Meta description (188 chars)
Compounded GLP-1 (custom-mixed semaglutide or tirzepatide) is common in the US but not legally available through routine UK supply. The MHRA position, why this matters, and what to verify.
Tier 3 and Tier 4 NHS weight management services explained
Meta description (186 chars)
The NHS weight management framework runs in four tiers. Tier 3 is specialist multi-disciplinary support; Tier 4 is bariatric surgery. NHS Mounjaro under TA1026 is commissioned at Tier 3.
GLP-1 medications often reduce alcohol cravings and tolerance. The neuroscience, the published observational data, and what UK prescribers typically advise. Encyclopedia framing only.
ApoB testing explained: the cardiovascular risk biomarker beyond LDL
Meta description (195 chars)
Apolipoprotein B is a more accurate cardiovascular risk biomarker than LDL cholesterol. Why UK longevity clinics include it in baseline bloods, and how it complements standard NHS lipid profiles.
Half-life varies hugely across peptides, from minutes to days. Why stabilising modifications matter, and how DAC linker chemistry extends half-life dramatically.
Sarcopenia and GLP-1: why muscle loss matters during rapid weight loss
Meta description (196 chars)
Sarcopenia is age-related muscle loss. GLP-1 medications accelerate weight loss including lean mass. The mechanism, the clinical context, and why preservation strategies matter especially post-50.
The leaflet inside every UK medicine box. The authoritative source on dosing, side effects, missed-dose advice. How PILs are produced, who approves them, and why they trump web content.
UK licensed GLP-1 medications are delivered in pre-filled pens or single-use vials. The two formats differ on dose control, ease of use, and waste. The current UK position for Mounjaro and Wegovy.
The Merrifield 1963 method for building peptides one amino acid at a time on an insoluble resin. Why peptide cost scales non-linearly with amino acid length.
Lp(a) explained: the inherited cardiovascular risk you cannot lifestyle away
Meta description (202 chars)
Lipoprotein(a) is a genetically-determined cardiovascular risk marker. Levels are set by your DNA and barely move with diet, exercise, or statins. Why every adult should know their Lp(a), measured once.
The UK system for reporting suspected adverse drug reactions. Patients and clinicians can submit at yellowcard.mhra.gov.uk. How it feeds into UK medicines safety surveillance.
HPLC purity explained (what 99%+ does and does not prove)
Meta description (195 chars)
High-Performance Liquid Chromatography measures peptide purity by separating components and reading the proportion of the named peptide. 99%+ does not prove activity, sterility, or dose accuracy.
Perimenopause and GLP-1: weight gain, HRT interactions, what works (UK)
Meta description (203 chars)
UK guide to GLP-1 medication during perimenopause. Why menopause weight is different. HRT interactions. Lancet Jan 2026 RCT on HRT-augmented loss. BMS guidance on oral progesterone absorption. Editorial.
UK Metabolic is funded by referral fees from clinic and pharmacy partners when readers click through and complete a consultation. We do not run third-party advertising, sell data, or let referral fees decide rankings. Full disclosure of commercial relationships.
After Mounjaro and Wegovy: aftercare, maintenance, and regain
Title tag (66 chars)
After Mounjaro and Wegovy: aftercare, maintenance, and regain (UK)
Meta description (185 chars)
UK aftercare guide for people stopping or maintaining on Mounjaro, Wegovy, and tirzepatide. 82% regain 25%+ in 12 months (Oxford, Jan 2026). What works, what does not, what to plan for.
UK guide to collagen supplements. Marine vs bovine vs vegan-builder. Type I, II, III. What the 2025 American Journal of Medicine meta-analysis says. UK affiliate via Awin retailers.
Type I, II, III collagen: which one for skin, joints, gut (UK)
Meta description (165 chars)
UK guide to collagen types. Type I for skin and tendons, Type II for cartilage and joints, Type III for skin and gut. Decoded plainly with UK product picks per goal.
Marine vs bovine vs vegan collagen UK: honest comparison
Meta description (196 chars)
UK comparison of marine collagen, bovine collagen, and so-called vegan collagen. Which is right for skin, joints, gut. Plus why vegan collagen does not technically exist (it is a precursor blend).
The full methodology UK Metabolic uses to rank UK longevity clinics. Bloods panel depth, imaging, body composition, intervention loop, evidence-base alignment.
Methodology: how we rank UK cosmetic peptide products
Meta description (181 chars)
The full methodology UK Metabolic uses to rank cosmetic peptide serums, creams and treatments. INCI position, declared concentration, base compatibility, packaging, UK availability.
The full methodology UK Metabolic uses to rank UK collagen brands. Type, dose, kDa molecular weight, source transparency, third-party testing, price per effective gram.
Methodology: how we rank UK research peptide retailers
Meta description (178 chars)
The full methodology UK Metabolic uses to rank research peptide retailers. HPLC purity, CoA transparency, UK warehouse, payment, customer-service responsiveness, trading history.
Methodology: how we rank UK GLP-1 clinics and pharmacies
Meta description (179 chars)
The full methodology UK Metabolic uses to rank GLP-1 clinics and online pharmacies. GPhC registration, prescriber model, pricing transparency, switching policy, aftercare framing.
Research peptides UK: encyclopedia and retailer comparison
Meta description (212 chars)
UK guide to research peptides. BPC-157, MOTS-c, ipamorelin and others. Encyclopedia framing only. UK retailer comparison: my-peptides, Pure Peptides UK, Direct Sarms. Research use only, not for human consumption.
Ipamorelin (UK): Novo Nordisk history, why pharmaceutical development stopped
Meta description (199 chars)
UK encyclopedia entry for ipamorelin. Originally developed by Novo Nordisk as a growth-hormone secretagogue. Phase II discontinued for postoperative ileus. No FDA or MHRA approval. Research use only.
UK encyclopedia entry for sermorelin. Growth-hormone-releasing-hormone analogue, formerly FDA-approved (Geref) for paediatric growth hormone deficiency. Withdrawn 2008. Now research-peptide market only in the UK.
TB-500 (UK): what it is, animal evidence, regulatory status
Meta description (156 chars)
UK encyclopedia entry for TB-500. Synthetic fragment of thymosin beta-4. Tissue repair animal data, no human RCTs. UK regulatory framing. Research use only.
UK research peptide retailers compared: my-peptides, Pure Peptides, Direct Sarms
Meta description (180 chars)
UK research peptide retailer comparison. my-peptides, Pure Peptides UK, Direct Sarms, Aquila, Pinnacle, Nooku. Purity claims, third-party testing, CoA standards, delivery, payment.
Melanotan (UK): MHRA enforcement history and warning
Meta description (239 chars)
UK encyclopedia entry for Melanotan I and II. Synthetic alpha-MSH analogues. Subject to active MHRA enforcement and explicit consumer safety warnings. Research-only framing carries higher enforcement risk for this peptide than most others.
Epitalon (UK): pineal peptide bioregulator, what is known
Meta description (199 chars)
UK encyclopedia entry for Epitalon (epithalon). Khavinson group telomerase research, pineal-gland focus, longevity claims. Russian literature dominant, limited Western replication. Research use only.
MOTS-c (UK): mitochondrial peptide, longevity literature, what is known
Meta description (172 chars)
UK encyclopedia entry for MOTS-c. Mitochondrial-derived peptide. Late-life intervention data in mice (Nature Communications 2020). UK regulatory framing. Research use only.
BPC-157 (UK): what it is, animal evidence, regulatory status
Meta description (192 chars)
UK encyclopedia entry for BPC-157. What the molecule is, what the animal literature shows, why no human RCTs exist, UK regulatory framing. No dosing. No human-use protocols. Research use only.
Tesamorelin (UK): the only research peptide with FDA approval
Meta description (243 chars)
UK encyclopedia entry for tesamorelin. Growth-hormone-releasing-hormone analogue. The only peptide on this list with an FDA-approved indication (HIV-associated lipodystrophy, EGRIFTA WR). Not NHS-prescribed. Research use only via UK retailers.
GHK-Cu (research tier, UK): the systemic peptide vs the cosmetic ingredient
Meta description (180 chars)
UK encyclopedia entry for GHK-Cu in the research-tier (injected / systemic) framing. Distinct from the cosmetic / topical use covered separately. Pickart group historical research.
Shop UK peptide products: where to buy cosmetic, collagen, research peptides
Meta description (219 chars)
Shop directory for UK peptide products. Cosmetic peptide skincare via Cult Beauty, Boots, LookFantastic. Collagen via Holland and Barrett, Bare Biology. Research peptides via my-peptides, Pure Peptides UK, Direct Sarms.
Live tracker of NHS England Mounjaro rollout by Integrated Care Board. 42 ICBs, each at a different stage of Cohort 1, 2 and 3 implementation. Refreshed monthly.
All 42 English ICBs: NHS GLP-1 access by region (2026)
Meta description (185 chars)
Per-ICB editorial pages on NHS Mounjaro and Wegovy access for all 42 NHS England Integrated Care Boards. Population served, neighbouring ICBs, rollout framework, NHS and private routes.
Shropshire, Telford and Wrekin NHS GLP-1 access (2026): rollout and routes
Meta description (225 chars)
NHS Mounjaro and Wegovy rollout for Shropshire, Telford and Wrekin ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Hertfordshire and West Essex NHS GLP-1 access (2026): rollout and routes
Meta description (223 chars)
NHS Mounjaro and Wegovy rollout for Hertfordshire and West Essex ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
South West London NHS GLP-1 access (2026): rollout and routes
Meta description (212 chars)
NHS Mounjaro and Wegovy rollout for South West London ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Somerset NHS GLP-1 access (2026): rollout and routes
Meta description (203 chars)
NHS Mounjaro and Wegovy rollout for Somerset ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Cornwall and the Isles of Scilly: NHS GLP-1 access
Title tag (76 chars)
Cornwall and the Isles of Scilly NHS GLP-1 access (2026): rollout and routes
Meta description (227 chars)
NHS Mounjaro and Wegovy rollout for Cornwall and the Isles of Scilly ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Hampshire and Isle of Wight NHS GLP-1 access (2026): rollout and routes
Meta description (222 chars)
NHS Mounjaro and Wegovy rollout for Hampshire and Isle of Wight ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
West Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (209 chars)
NHS Mounjaro and Wegovy rollout for West Yorkshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
North West London NHS GLP-1 access (2026): rollout and routes
Meta description (212 chars)
NHS Mounjaro and Wegovy rollout for North West London ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Leicester, Leicestershire and Rutland: NHS GLP-1 access
Title tag (81 chars)
Leicester, Leicestershire and Rutland NHS GLP-1 access (2026): rollout and routes
Meta description (232 chars)
NHS Mounjaro and Wegovy rollout for Leicester, Leicestershire and Rutland ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
North East and North Cumbria NHS GLP-1 access (2026): rollout and routes
Meta description (223 chars)
NHS Mounjaro and Wegovy rollout for North East and North Cumbria ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Bedfordshire, Luton and Milton Keynes: NHS GLP-1 access
Title tag (81 chars)
Bedfordshire, Luton and Milton Keynes NHS GLP-1 access (2026): rollout and routes
Meta description (232 chars)
NHS Mounjaro and Wegovy rollout for Bedfordshire, Luton and Milton Keynes ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Sussex NHS GLP-1 access (2026): rollout and routes
Meta description (201 chars)
NHS Mounjaro and Wegovy rollout for Sussex ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Cambridgeshire and Peterborough NHS GLP-1 access (2026): rollout and routes
Meta description (226 chars)
NHS Mounjaro and Wegovy rollout for Cambridgeshire and Peterborough ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Lincolnshire NHS GLP-1 access (2026): rollout and routes
Meta description (207 chars)
NHS Mounjaro and Wegovy rollout for Lincolnshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Birmingham and Solihull NHS GLP-1 access (2026): rollout and routes
Meta description (218 chars)
NHS Mounjaro and Wegovy rollout for Birmingham and Solihull ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Nottingham and Nottinghamshire NHS GLP-1 access (2026): rollout and routes
Meta description (225 chars)
NHS Mounjaro and Wegovy rollout for Nottingham and Nottinghamshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Black Country NHS GLP-1 access (2026): rollout and routes
Meta description (208 chars)
NHS Mounjaro and Wegovy rollout for Black Country ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Lancashire and South Cumbria NHS GLP-1 access (2026): rollout and routes
Meta description (223 chars)
NHS Mounjaro and Wegovy rollout for Lancashire and South Cumbria ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Northamptonshire NHS GLP-1 access (2026): rollout and routes
Meta description (211 chars)
NHS Mounjaro and Wegovy rollout for Northamptonshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Coventry and Warwickshire NHS GLP-1 access (2026): rollout and routes
Meta description (220 chars)
NHS Mounjaro and Wegovy rollout for Coventry and Warwickshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Derby and Derbyshire NHS GLP-1 access (2026): rollout and routes
Meta description (215 chars)
NHS Mounjaro and Wegovy rollout for Derby and Derbyshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Buckinghamshire, Oxfordshire and Berkshire West: NHS GLP-1 access
Title tag (91 chars)
Buckinghamshire, Oxfordshire and Berkshire West NHS GLP-1 access (2026): rollout and routes
Meta description (242 chars)
NHS Mounjaro and Wegovy rollout for Buckinghamshire, Oxfordshire and Berkshire West ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Humber and North Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (221 chars)
NHS Mounjaro and Wegovy rollout for Humber and North Yorkshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Bristol, North Somerset and South Gloucestershire: NHS GLP-1 access
Title tag (93 chars)
Bristol, North Somerset and South Gloucestershire NHS GLP-1 access (2026): rollout and routes
Meta description (244 chars)
NHS Mounjaro and Wegovy rollout for Bristol, North Somerset and South Gloucestershire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
NHS Mounjaro and Wegovy rollout for Devon ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Frimley NHS GLP-1 access (2026): rollout and routes
Meta description (202 chars)
NHS Mounjaro and Wegovy rollout for Frimley ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Staffordshire and Stoke-on-Trent: NHS GLP-1 access
Title tag (76 chars)
Staffordshire and Stoke-on-Trent NHS GLP-1 access (2026): rollout and routes
Meta description (227 chars)
NHS Mounjaro and Wegovy rollout for Staffordshire and Stoke-on-Trent ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
North East London NHS GLP-1 access (2026): rollout and routes
Meta description (212 chars)
NHS Mounjaro and Wegovy rollout for North East London ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Dorset NHS GLP-1 access (2026): rollout and routes
Meta description (201 chars)
NHS Mounjaro and Wegovy rollout for Dorset ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
North Central London NHS GLP-1 access (2026): rollout and routes
Meta description (215 chars)
NHS Mounjaro and Wegovy rollout for North Central London ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Suffolk and North East Essex NHS GLP-1 access (2026): rollout and routes
Meta description (223 chars)
NHS Mounjaro and Wegovy rollout for Suffolk and North East Essex ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
South East London NHS GLP-1 access (2026): rollout and routes
Meta description (212 chars)
NHS Mounjaro and Wegovy rollout for South East London ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Herefordshire and Worcestershire: NHS GLP-1 access
Title tag (76 chars)
Herefordshire and Worcestershire NHS GLP-1 access (2026): rollout and routes
Meta description (227 chars)
NHS Mounjaro and Wegovy rollout for Herefordshire and Worcestershire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Gloucestershire NHS GLP-1 access (2026): rollout and routes
Meta description (210 chars)
NHS Mounjaro and Wegovy rollout for Gloucestershire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Norfolk and Waveney NHS GLP-1 access (2026): rollout and routes
Meta description (214 chars)
NHS Mounjaro and Wegovy rollout for Norfolk and Waveney ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Bath, North East Somerset, Swindon and Wiltshire: NHS GLP-1 access
Title tag (92 chars)
Bath, North East Somerset, Swindon and Wiltshire NHS GLP-1 access (2026): rollout and routes
Meta description (243 chars)
NHS Mounjaro and Wegovy rollout for Bath, North East Somerset, Swindon and Wiltshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Kent and Medway NHS GLP-1 access (2026): rollout and routes
Meta description (210 chars)
NHS Mounjaro and Wegovy rollout for Kent and Medway ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Mid and South Essex NHS GLP-1 access (2026): rollout and routes
Meta description (214 chars)
NHS Mounjaro and Wegovy rollout for Mid and South Essex ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
South Yorkshire NHS GLP-1 access (2026): rollout and routes
Meta description (210 chars)
NHS Mounjaro and Wegovy rollout for South Yorkshire ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Greater Manchester NHS GLP-1 access (2026): rollout and routes
Meta description (213 chars)
NHS Mounjaro and Wegovy rollout for Greater Manchester ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Cheshire and Merseyside NHS GLP-1 access (2026): rollout and routes
Meta description (218 chars)
NHS Mounjaro and Wegovy rollout for Cheshire and Merseyside ICB. Cohort 1 live since June 2025; Cohort 2 launches 23 June 2026. Specialist weight management referral routes, NICE TA1026 framework, private alternatives.
Best UK longevity clinics (2026): full bloods, biomarkers, follow-up compared
Meta description (171 chars)
UK editorial comparison of leading longevity clinics in 2026. Full-panel bloods, biomarker testing, VO2 max, DXA, hormone optimisation. Strengths and price tiers compared.
Best UK GLP-1 clinics for women 2026: Mounjaro and Wegovy
Meta description (167 chars)
UK editorial list of the best GLP-1 clinics for women in 2026. Menopause-aware care, HRT coordination, fertility-aware prescribing. Editorial. Your prescriber decides.
Best UK Tesamorelin retailers (2026): HPLC purity, CoA, delivery compared
Meta description (154 chars)
UK editorial comparison of where to buy Tesamorelin research peptide in 2026. Six UK retailers compared. Research use only. No UK marketing authorisation.
Best UK collagen brands 2026: marine, bovine, vegan compared
Meta description (170 chars)
UK editorial list of the best collagen supplements 2026. Ranked on type, source, dose per serving, kDa molecular weight, third-party testing, and cost per effective gram.
Best UK BPC-157 retailers (2026): HPLC purity, CoA, delivery compared
Meta description (178 chars)
UK editorial comparison of where to buy BPC-157 research peptide in 2026. Six UK retailers compared on HPLC purity, Certificate of Analysis, delivery, payment. Research use only.
Best UK Ipamorelin retailers (2026): HPLC purity, CoA, delivery compared
Meta description (181 chars)
UK editorial comparison of where to buy Ipamorelin research peptide in 2026. Six UK retailers compared on HPLC purity, Certificate of Analysis, delivery, payment. Research use only.
Best UK marine collagen (2026): dose, kDa, source, price compared
Meta description (190 chars)
UK editorial list of the 8 best marine collagen supplements in 2026. Ranked on dose per serving, kDa molecular weight, source transparency, third-party testing, and price per effective gram.
Best UK collagen for menopause 2026: skin, joints, hair thinning
Meta description (172 chars)
UK editorial list of the best collagen supplements for menopause and perimenopause 2026. Skin laxity, joint discomfort, hair thinning. Marine vs bovine vs precursor blends.
Best UK GLP-1 clinics (2026): Numan, Voy, Manual, Juniper compared
Meta description (174 chars)
UK editorial comparison of the leading GLP-1 medication clinics in 2026. High-touch programmes with coach plus prescriber. Strengths, weaknesses, pricing, and who each suits.
UK editorial list of the 10 GHK-Cu copper peptide serums worth considering in 2026. INCI position, declared concentration where available, where to buy. Affiliate disclosure.
Best UK copper peptide creams and moisturisers (2026)
Meta description (161 chars)
UK editorial list of copper peptide creams and moisturisers (as distinct from serums). Ranked on INCI position, supporting actives, base compatibility and price.
PCOS and GLP-1: insulin resistance, fertility, off-label tirzepatide (UK)
Meta description (198 chars)
UK guide to GLP-1 medication for PCOS. Off-label tirzepatide for insulin resistance. NHS unlikely to fund for PCOS specifically. Fertility timing rule (stop 2-3 months before conception). Editorial.
How NHS Mounjaro and Wegovy access works in each UK nation. England Cohort 1/2/3, Scotland BMI 30 specialist-only, Wales TA1026 timing, Northern Ireland 2026 rollout. One page, all four nations.
About UK Metabolic: editorial comparison for GLP-1, peptides, longevity
Meta description (262 chars)
UK Metabolic is a UK editorial comparison service covering GLP-1 medications, research peptides, cosmetic peptides, collagen, and longevity clinics. Not a pharmacy. Not a clinic. Operated by Best Business Loans Ltd (16833937). Editorial director: Oliver Mackman.
GLP-1 and protein: muscle preservation, target intake, UK food sources
Meta description (229 chars)
UK guide to protein intake on Mounjaro and Wegovy. Up to half of GLP-1 weight loss can be non-fat. Target 1.4-1.8g/kg goal weight. Practical UK food list, supplement options, and how to hit the number when appetite is suppressed.
UK GLP-1 cost and supply tracking. Sept 2025 Lilly raised Mounjaro UK prices up to 170%. Per-route current pricing, supply state, what to do when your pharmacy is out of stock.
In September 2025, Eli Lilly raised UK Mounjaro list prices by up to 170 percent. The context, the pass-through, and what UK patients saw at the pharmacy. Editorial commentary.
UK Saxenda (liraglutide) pricing in May 2026. Daily injection, older GLP-1, largely superseded by Wegovy and Mounjaro in 2025 to 2026. NHS routes, private clinic and pharmacy options.
UK Mounjaro pricing in May 2026 across NHS, high-touch clinics, and low-touch pharmacies. Post-September-2025 Lilly price shock, dose-tier costs, and what the £150 to £300 monthly range buys you.
UK GLP-1 access splits into two routes: NHS at £9.90 prescription charge if eligible, or private at £149 to £349 per month. Eligibility, wait times, programme depth, and the trade-offs.
UK Wegovy (semaglutide) pricing in May 2026 across NHS, high-touch clinics, and low-touch pharmacies. Why Wegovy pricing stayed more stable than Mounjaro through 2025 to 2026, plus dose-tier costs.
UK Mounjaro and Wegovy clinics: high-touch private route compared (v0.2)
Meta description (193 chars)
UK private clinic directory for Mounjaro and Wegovy. Numan, Voy, Manual, Juniper, Newson Health and others. App, coach, monthly check-in. £200 to £300 per month typical. Editorial. Coming v0.2.
How UK Metabolic researches, sources, fact-checks, and signs off content. NICE, MHRA, NHS guidance. Named prescriber byline on regulatory pages. ASA CAP code compliance.
GLP-1 protein calculator (UK): grams per day to preserve lean mass
Meta description (219 chars)
Free UK calculator. Enter goal weight and activity level to get a daily protein target while on Mounjaro or Wegovy. Based on the 1.4 to 1.8 g per kg goal weight evidence range for muscle preservation in calorie deficit.
Collagen dose calculator (UK): how many grams per day for skin or joints
Meta description (200 chars)
Free UK calculator. Enter goal (skin, joints, recovery), body weight and age and get an evidence-based collagen dose target in grams per day. Based on the Bolke 2019 RCT and Shaw 2017 tendon protocol.
Mounjaro face and Ozempic face: UK editorial on GLP-1 facial volume loss
Meta description (172 chars)
Honest UK editorial on the facial volume loss attributed to rapid GLP-1 weight loss. What the evidence shows, what aesthetic clinics offer, what you can do without surgery.
Peptides and metabolic health glossary (UK plain English)
Meta description (164 chars)
UK plain-English glossary for peptide skincare, collagen, research peptides, GLP-1 medications, and the regulators behind them. DefinedTermSet schema for AI search.
Body recomp and excess skin after Mounjaro: UK pathway
Meta description (213 chars)
After GLP-1 weight loss, around 39% of patients consider plastic surgery for excess skin within 18 months. UK pathway: when to wait, when to consult, surgeon options, costs, resistance-training-first alternatives.
UK online pharmacies for Mounjaro and Wegovy: low-touch route compared (v0.2)
Meta description (197 chars)
UK online pharmacy directory for Mounjaro and Wegovy. Phlo, Pharmacy2U, SimplyMeds, Boots Online Doctor, Asda Online Doctor. Questionnaire then ship. £150 to £200 per month. Editorial. Coming v0.2.
UK retailers stocking MOTS-c research peptide in 2026. my-peptides, Pure Peptides UK, Direct Sarms compared. Research use only, not for human consumption.
UK retailers stocking Tesamorelin research peptide in 2026. Note: Tesamorelin is FDA-approved (EGRIFTA) for HIV-associated lipodystrophy but has no UK marketing authorisation. UK retailers sell under research-use-only framing.
Where to buy GHK-Cu copper peptides in the UK (2026)
Meta description (156 chars)
UK retailers stocking GHK-Cu copper peptide skincare in 2026. Cult Beauty, Boots, LookFantastic, Beauty Pie, Space NK compared. Top serums by INCI position.
Where to buy Mounjaro in the UK (2026): NHS, clinic, pharmacy compared
Meta description (201 chars)
How to get Mounjaro in the UK in 2026. NHS Cohort 1 live, Cohort 2 from 23 June 2026. Private clinics (Numan, Voy, Manual, Juniper) and online pharmacies (Phlo, Pharmacy2U, SimplyMeds, Boots) compared.
UK retailer reviews: peptide and GLP-1 clinics, pharmacies, research peptide suppliers
Meta description (180 chars)
Editorial reviews of every UK clinic, pharmacy and research peptide supplier we link to. Numan, Voy, Manual, Juniper, Phlo, Pharmacy2U, my-peptides, Pure Peptides UK, Direct Sarms.
UK editorial review of Phlo. App-based UK pharmacy with fast turnaround and strong UK-wide delivery. Among the lowest cost per dose in the low-touch tier. Last reviewed 2026-05-10.
Direct Sarms review (UK): Research peptide retailer (peptides + SARMs)
Meta description (184 chars)
UK editorial review of Direct Sarms. UK-shipping retailer with research peptides alongside SARMs. Crypto payment option for EU customers in addition to cards. Last reviewed 2026-05-10.
my-peptides review (UK): Research peptide retailer
Meta description (194 chars)
UK editorial review of my-peptides. UK research peptide retailer with HPLC-verified purity claims and CoAs included on orders. Operates under research-use-only framing. Last reviewed 2026-05-10.
UK editorial review of Voy. Programme-style weight management clinic with strong emphasis on aftercare and maintenance. Was Second Nature historically. Last reviewed 2026-05-10.
UK editorial review of SimplyMeds. UK online pharmacy with competitive Mounjaro and Wegovy pricing after the September 2025 price shock. Questionnaire-then-ship model. Same-day dispatch from UK warehouse on weekdays. Last reviewed 2026-05-11.
UK editorial review of Juniper. Women-led weight management clinic with menopause and hormonal-context awareness baked into the consult. The clinic most likely to coordinate with HRT. Last reviewed 2026-05-10.
Vital Proteins UK review (UK): Collagen (multinational brand, UK distribution)
Meta description (222 chars)
UK editorial review of Vital Proteins UK. Largest global collagen brand. UK distribution via Cult Beauty, LookFantastic, Amazon UK, and direct. Marine and bovine ranges; flavoured and unflavoured. Last reviewed 2026-05-11.
Bare Biology review (UK): Marine collagen (UK independent brand)
Meta description (219 chars)
UK editorial review of Bare Biology. UK independent brand specialising in marine collagen and omega-3 oils. Wild-caught North Atlantic sourcing, third-party tested, plastic-conscious packaging. Last reviewed 2026-05-11.
Pure Peptides UK review (UK): Research peptide retailer
Meta description (198 chars)
UK editorial review of Pure Peptides UK. Long-established UK research peptide supplier. Range overlaps with my-peptides plus some specialist peptides not stocked elsewhere. Last reviewed 2026-05-10.